The Impact of COVID-19 is included in Advanced Therapy Medicinal Products Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Advanced Therapy Medicinal Products Trends and Forecast
The future of the global advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets. The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases, and favorable regulatory environment and growing government support.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Advanced Therapy Medicinal Products by Segment
The study includes a forecast for the global advanced therapy medicinal products by product and region.
Advanced Therapy Medicinal Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• Cell Therapy
• CAR-T Therapy
• Gene Therapy
• Tissue Engineered Product
Advanced Therapy Medicinal Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Advanced Therapy Medicinal Products Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies advanced therapy medicinal products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the advanced therapy medicinal products companies profiled in this report include-
• Spark Therapeutics
• Bluebird Bio
• Novartis
• Uniqure
• Celgene Corporation
• Gilead Lifesciences
• Kolon Tissuegene
• JCR Pharmaceuticals
• Medipost
• Vericel Corporation
Advanced Therapy Medicinal Products Market Insights
Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.
North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.
Features of the Global Advanced Therapy Medicinal Products Market
Market Size Estimates: Advanced therapy medicinal products market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Advanced therapy medicinal products size by product and region in terms of value ($B).
Regional Analysis: Advanced therapy medicinal products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products and regions for the mucopolysaccharidosis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the advanced therapy medicinal products market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the advanced therapy medicinal products market size?
Answer: The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030.
Q.2 What is the growth forecast for advanced therapy medicinal products market?
Answer: The global advanced therapy medicinal products market is expected to grow with a CAGR of 13.5% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the advanced therapy medicinal products market?
Answer: The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases and favorable regulatory environment and growing government support.
Q4. What are the major segments for advanced therapy medicinal products market?
Answer: The future of the advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets.
Q5. Who are the key advanced therapy medicinal products market companies?
Answer: Some of the key advanced therapy medicinal products companies are as follows:
• Spark Therapeutics
• Bluebird Bio
• Novartis
• Uniqure
• Celgene Corporation
• Gilead Lifesciences
• Kolon Tissuegene
• JCR Pharmaceuticals
• Medipost
• Vericel Corporation
Q6. Which advanced therapy medicinal products market segment will be the largest in future?
Answer: Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.
Q7. In advanced therapy medicinal products market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the advanced therapy medicinal products market by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Advanced Therapy Medicinal Products Market, Advanced Therapy Medicinal Products Market Size, Advanced Therapy Medicinal Products Market Growth, Advanced Therapy Medicinal Products Market Analysis, Advanced Therapy Medicinal Products Market Report, Advanced Therapy Medicinal Products Market Share, Advanced Therapy Medicinal Products Market Trends, Advanced Therapy Medicinal Products Market Forecast, Advanced Therapy Medicinal Products Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Advanced Therapy Medicinal Products Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Advanced Therapy Medicinal Products Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Advanced Therapy Medicinal Products Market by Product
3.3.1: Cell Therapy
3.3.2: CAR-T Therapy
3.3.3: Gene Therapy
3.3.4: Tissue Engineered Product
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Advanced Therapy Medicinal Products Market by Region
4.2: North American Advanced Therapy Medicinal Products Market
4.3: European Advanced Therapy Medicinal Products Market
4.3.1: European Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
4.4: APAC Advanced Therapy Medicinal Products Market
4.4.1: APAC Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
4.5: ROW Advanced Therapy Medicinal Products Market
4.5.1: ROW Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Product
6.1.2: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Region
6.2: Emerging Trends in the Global Advanced Therapy Medicinal Products Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Advanced Therapy Medicinal Products Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Advanced Therapy Medicinal Products Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Spark Therapeutics
7.2: Bluebird Bio
7.3: Novartis
7.4: UniQure
7.5: Celgene Corporation
7.6: Gilead Lifesciences
7.7: Kolon TissueGene
7.8: JCR Pharmaceuticals
7.9: MEDIPOST
7.10: Vericel Corporation
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Advanced Therapy Medicinal Products Market Report.